The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; ClearCut Medical; Clovis Oncology; Daiichi Sankyo Europe GmbH; Eisai Germany; Exact Sciences; Gilead Sciences; Lilly; Merck; MSD Oncology; Novartis; Pfizer; pfm medical; Roche; Seagen; Seagen; Servier/Pfizer; Servier/Pfizer; Sysmex; Vifor Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Becton Dickinson; Biom‘Up; ClearCut Medical; Clovis Oncology; Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Lilly; Merck; MSD Oncology; Neodynamics; Novartis; Pfizer; pfm medical; Pierre Fabre; Roche; Seagen; Sysmex; Viatris
Research Funding - Endomag (Inst); Exact Sciences (Inst)
Expert Testimony - pfm medical
Travel, Accommodations, Expenses - ClearCut Medical; Lilly; Pfizer; pfm medical; Roche
 
Honoraria - Agendia; Amgen; Aristo; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene/Jazz; ClinSol; Daiichi Sankyo; Eisai; Exact Sciences; Genomic Health; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Medstrom Medical; MSD; Mundipharma; Mylan; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva; Veracyte; Viatris
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva
Speakers' Bureau - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seattle Genetics/Astellas; Tesaro; Teva
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; Boehringer Ingelheim; Carl Zeiss Meditec; Celgene; Daiichi Sankyo; Eisai; Genomic Health; GlaxoSmithKline; Lilly; MSD; NanoString Technologies; Novartis; Odonate Therapeutics; Palleos; Paxman; Pfizer; Pierre Fabre; Puma Biotechnology; Riemser; Roche; Sandoz/Hexal; Seagen; Tesaro; Teva
Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer: ADAPTcycle.
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - Amgen; AstraZeneca; Daiichi-Sankyo; Exact Sciences; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sandoz; Seagen; West German Study Group (I)
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Genomic Health; NanoString Technologies; Novartis; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Amgen; Daiichi Sankyo; Genomic Health; Gilead Sciences; Lilly; Merck Sharp & Dohme; MolecularHealth; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
 
Matthias Christgen
No Relationships to Disclose
 
Michael Braun
Consulting or Advisory Role - Exact Sciences; Novartis
Speakers' Bureau - Novartis
 
Marc Thill
No Relationships to Disclose
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Kerstin Luedtke-Heckenkamp
Honoraria - AstraZeneca Canada; AstraZeneca/Daiichi Sankyo; Eisai Germany; Novartis; Pfizer; Roche
Consulting or Advisory Role - Merck Serono; Novartis; Roche Pharma AG; Seagen
Research Funding - Eisai Germany (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene/Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Monika Graeser
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca Canada; Daiichi Sankyo
 
Felix Hilpert
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD
Expert Testimony - AstraZeneca; GlaxoSmithKline; MSD
 
Vesna Bjelic-Radisic
Speakers' Bureau - Lilly (Inst)
 
Katja Krauss
Stock and Other Ownership Interests - Sanofi
Honoraria - Roche Pharma AG
 
Mathias Warm
No Relationships to Disclose
 
Matthias R. Zaiss
No Relationships to Disclose
 
Andreas D. Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca Canada; Daiichi Sankyo; Exact Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Marianne Just
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Roche Pharma AG
 
Ulrike Nitz
Honoraria - Agendia; Amgen; AstraZeneca; Celgene; Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche/Genentech; Seagen
Consulting or Advisory Role - Genomic health; Roche
Research Funding - Amgen (Inst); Celgene (Inst); Exact Sciences (Inst); NanoString Technologies (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Exact Sciences
Travel, Accommodations, Expenses - Exact Sciences; Pfizer; Roche
 
Christine zu Eulenburg
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Genomic Health; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche/Genentech; Seagen; SOMATEX; Sonoscape
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche; Sonoscape
(OPTIONAL) Uncompensated Relationships - West German Study Group